Century Therapeutics (IPSC) Return on Invested Capital (2022 - 2024)
Historic Return on Invested Capital for Century Therapeutics (IPSC) over the last 3 years, with Q4 2024 value amounting to 0.78%.
- Century Therapeutics' Return on Invested Capital fell 500.0% to 0.78% in Q4 2024 from the same period last year, while for Dec 2024 it was 0.78%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.81% for FY2024, which is 2100.0% down from last year.
- Century Therapeutics' Return on Invested Capital amounted to 0.78% in Q4 2024, which was down 500.0% from 0.69% recorded in Q3 2024.
- Over the past 5 years, Century Therapeutics' Return on Invested Capital peaked at 0.42% during Q4 2022, and registered a low of 0.81% during Q1 2024.
- For the 3-year period, Century Therapeutics' Return on Invested Capital averaged around 0.63%, with its median value being 0.69% (2024).
- Over the last 5 years, Century Therapeutics' Return on Invested Capital had its largest YoY gain of -500bps in 2024, and its largest YoY loss of -3700bps in 2024.
- Quarter analysis of 3 years shows Century Therapeutics' Return on Invested Capital stood at 0.42% in 2022, then crashed by -77bps to 0.74% in 2023, then decreased by -7bps to 0.78% in 2024.
- Its Return on Invested Capital stands at 0.78% for Q4 2024, versus 0.69% for Q3 2024 and 0.73% for Q2 2024.